Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2017-08-02 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
独立董事提名人声明和候选人声明
Board/Management Information Classification · 95% confidence The document is a nomination statement and declaration for an independent director candidate at Zhengzhou Antu Bioengineering Co., Ltd. It contains detailed qualifications, legal compliance, and independence criteria for the director candidate, as well as the candidate's own declaration and commitment. There are no financial statements, earnings data, or report attachments. The document is a formal announcement related to board/management information, specifically about the nomination and qualifications of a board member. It is not an annual report, audit report, earnings release, or any other financial report. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3640 characters, which is consistent with a detailed announcement rather than a full report.
2017-08-02 Chinese
招商证券股份有限公司关于公司使用闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from the sponsor institution (招商证券股份有限公司) regarding the use of idle raised funds by 郑州安图生物工程股份有限公司 for cash management. It references regulatory approvals, fundraising details, investment plans, risk analysis, and compliance with relevant laws and stock exchange rules. The document is not a financial report like an annual or interim report, nor is it a brief announcement or voting result. It is a formal verification and audit opinion related to the use of raised funds, which fits the category of Audit Report / Information (AR). The document length is under 5,000 characters but contains substantive content and detailed verification, not just an announcement or certification letter, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. H1 2017
2017-08-02 Chinese
第二届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 14th meeting of the second board of directors of Zhengzhou Antu Biological Engineering Co., Ltd. It includes information about board meeting procedures, voting results, nomination of an independent director candidate, approval of financial management proposals, and dividend distribution plans. The content focuses on board decisions and changes in board composition, including the nomination of a new independent director and related committee appointments. There is no full financial report or earnings data presented, but rather board meeting resolutions and governance matters. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2017-08-02 Chinese
2017年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '2017 年半年度报告摘要' which translates to '2017 Half-Year Report Summary'. It contains detailed financial data for the first half of 2017, including total assets, net profit, revenue, earnings per share, and other financial metrics. It also includes management discussion and analysis of business operations, changes in accounting policies, and other substantive financial information. The document length is 4125 characters, which is relatively short but contains actual financial data and analysis, not just an announcement or summary pointing to a full report. The content matches the characteristics of an Interim / Quarterly Report (IR), which covers a period shorter than a full fiscal year and includes substantive financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2017
2017-08-02 Chinese
2017年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2017 年半年度报告' which translates to '2017 Semi-Annual Report'. It contains detailed financial data, including revenue, net profit, cash flow, and other financial metrics for the period January 1 to June 30, 2017. The document includes sections such as company overview, business summary, management discussion and analysis, financial statements, and notes. It explicitly states it is a half-year report and includes comprehensive financial and operational information, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-02 Chinese
2017年上半年募集资金存放和实际使用情况专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2017 年上半年募集资金存放和实际使用情况专项报告" which translates to "2017 First Half Year Special Report on the Storage and Actual Use of Raised Funds." It details the management, storage, and actual use of funds raised by the company through an IPO, including investment projects, cash management, and compliance with regulatory requirements. The document references regulatory guidelines from the China Securities Regulatory Commission and Shanghai Stock Exchange regarding the management and use of raised funds. It includes detailed financial figures and tables about the raised funds, their usage, and investment returns. This type of document is a specialized report on the use of capital raised by the company, which fits the category of Capital/Financing Update (CAP). It is not a general annual or interim report, nor an earnings release or audit report. It is a substantive report with financial data about fundraising and capital usage, not merely an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2017-08-02 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.